Company profile
Proto Script Pharmaceutical Corp.
OTC: PSCR · Industrials · Specialty Business Services
#750 of 978 Industrials companies by revenuebottom-quartile growth
EA Score
——FH —DQ 7GM —SS 23
v0.1 · 25/100 weight · pillars only
↑ balance-sheet leverage, Piotroski F · ↓ return on equity, filing timeliness
Methodology →Revenue TTM
$605.0k
Rev growth YoY (TTM)
+75.2%
Net income (FY)
-$7.2M
Employees
13
as of 2026-08-29
Market cap
$4.9k
as of 2026-08-29
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$789.0k$789.0k2016
Net income-$7.2M-$7.2M2016
Operating income-$298.1k-$298.1k2016
Total assets$170.2k$170.2k2016
Liabilities$88.8k$88.8k2016
Equity-$319.7k-$319.7k2016
Revenue trend
FY2012 – FY2016 · USD
FY12
FY12
FY13
FY16
FY16
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Proto Script Pharmaceutical Corp.’s revenue?
Proto Script Pharmaceutical Corp. booked $789.0k in FY2016 revenue, contracting 10% year over year — slower than 78% of Industrials companies we track, at a -910.4% net margin.
Peers · Industrials
Profit Planners Management, Inc.——O.A.T., Inc.37DUnited Rail, Inc.——World Am, Inc.——OFA Group21DElectronic Control Security Inc.——Neighbors
San Bernardino →Key facts
CEOMichelle Rico
SectorIndustrials
IndustrySpecialty Business Services
HeadquartersRancho Cucamonga, CA
ExchangeOTC: PSCR
Employees13
IPO date2012-04-12
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.